1.北京中医药大学东直门医院 北京 100700
2.北京清华长庚医院
3.北京中医药大学研究生院
吕明圣,男,博士后
# 王洪武,男,博士,教授,主任医师,博士生导师,主要研究方向:中西医结合治疗呼吸系统疾病及肿瘤的研究,E-mail:wanghongwu2015@126.com
纸质出版日期:2023-08-30,
网络出版日期:2023-07-20,
收稿日期:2023-03-08,
移动端阅览
吕明圣, 王洪武, 李磊, 等. 基于络病理论探讨多发性肺结节诊疗策略[J]. 北京中医药大学学报, 2023,46(8):1166-1171.
LYU Mingsheng, WANG Hongwu, LI Lei, et al. Diagnosis and treatment of multiple pulmonary nodules based on collateral disease theory[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023,46(8):1166-1171.
吕明圣, 王洪武, 李磊, 等. 基于络病理论探讨多发性肺结节诊疗策略[J]. 北京中医药大学学报, 2023,46(8):1166-1171. DOI: 10.3969/j.issn.1006-2157.2023.08.016.
LYU Mingsheng, WANG Hongwu, LI Lei, et al. Diagnosis and treatment of multiple pulmonary nodules based on collateral disease theory[J]. Journal of Beijing University of Traditional Chinese Medicine, 2023,46(8):1166-1171. DOI: 10.3969/j.issn.1006-2157.2023.08.016.
多发性肺结节是临床常见病、多发病,早期筛查并合理干预高危结节是本病管理的重中之重。目前,对于肺结节中医病因病机的认识尚未统一。本文基于中医络病理论,提出内外相合、正虚络结是肺结节的基本病理基础,肺络阳虚不化、阴形累聚伏结是其关键病机,癌毒内蕴是结节恶化的中心环节。本文结合西医学的研究进展,论述中低危及高危肺结节的诊疗策略,总以扶阳抑阴、通络散结为基本治法进行辨证施治,益气温阳、化痰消瘀、解毒消积等多法并举,使气血通畅,阴阳既济,则结节无所复生。
Pulmonary nodules are common in clinical practice. Early screening of high-risk nodules and intervention are the top priority in the management of this disease. At present
the pathogenesis of pulmonary nodules in the field of traditional Chinese medicine (TCM) is still under discussion. Based on the theory of collateral diseases in TCM
we suppose that with the effect of internal and external pathogens
the basic pathological basis of pulmonary nodules is qi deficiency accompanied by phlegm and blood stasis in collateral vessels. The key pathogenesis of pulmonary nodules is yang deficiency and yin aggregation in pulmonary collateral vessels. Tumor toxin accumulation is the central cause of pulmonary nodule deterioration. Combined with recent studies of western medicine
we discuss the diagnosis and treatment of medium- to low-risk and high-risk pulmonary nodules. The basic treatment method is reinforcing yang and repressing yin
while dissipating phlegm and blood stasis from the pulmonary collateral vessels based on syndrome differentiations
and common treatments include tonifying qi
warming yang
resolving phlegm and accumulation
and detoxifying to dissipate nodules. Through all of these methods
the qi and blood will be harmonized
balancing yin and yang
and then dispersing the pulmonary nodules.
肺结节络病阳化气阴成形癌毒
pulmonary nodulescollateral diseaseqi transformation by yangaggregation accumulation by yintumor toxin
中华医学会呼吸病学分会肺癌学组,中国肺癌防治联盟专家组.肺结节诊治中国专家共识(2018年版)[J].中华结核和呼吸杂志,2018,41(10):763-771.
T TIAN, J LU, W ZHAO, et al. Associations of systemic inflammation markers with identification of pulmonary nodule and incident lung cancer in Chinese population[J]. Cancer Med, 2022,11(12):2482-2491.
徐国厚,黄海峡,陈斌,等.单体检中心23 695例体检者首次胸部低剂量CT筛查结果及肺结节相关易感因素的研究[J].复旦学报(医学版),2020,47(5):654-659.
HJ DE KONING, CM VAN DER AALST, PA DE JONG, et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial[J]. N Engl J Med, 2020,382(6):503-513.
LS KINSINGER, C ANDERSON, J KIM, et al. Implementation of Lung Cancer Screening in the Veterans Health Administration[J]. JAMA Intern Med, 2017,177(3):399-406.
PJ MAZZONE, L LAM. Evaluating the Patient With a Pulmonary Nodule: A Review[J]. JAMA, 2022,327(3):264-273.
上海市医师协会整合医学分会.肺部多发磨玻璃结节中西医结合防治一体化专家共识[J].肿瘤,2022,42(7):451-465.
周杰,王玥慧,李志明,等.络病学说指导下的肺结节“肺气亏虚,毒阻肺络”病机探讨[J].中国医药导报,2020,17(28):133-136.
林事成,周相男,刘殿娜,等.基于络病理论探讨肺结节结癌转化的防治[J].中医学报,2022,37(9):1825-1828.
张旻,陈起航,杨正汉,等.表现为局灶性纯磨玻璃密度影的肺癌:影像与病理对照分析[J].医学影像学杂志,2008,18(6):606-610.
吴以岭.络病学[M].2版.北京:中国中医药出版社,2017:21-39.
J KIM, B DABIRI, MM HAMMER. Micronodular lung disease on high-resolution CT: patterns and differential diagnosis[J]. Clin Radiol, 2021,76(6):399-406.
高伟,武维屏.浅谈中医药干预肺部结节结癌转化进程[J].中华中医药杂志,2021,36(1):217-220.
张妙芬,刘城鑫,黄慧婷,等.基于“阳化气,阴成形”理论探讨温阳散结法治疗肺结节[J].中医杂志,2021,62(22):1960-1962.
刘艳彬,徐梦娇,郑佳昆,等.从“阳化气,阴成形”失常论治肺结节[J].北京中医药,2022,41(5):543-545.
陆王娟,周贤梅.中医体质在肺结节早期诊治中的应用探讨[J].陕西中医,2018,39(4):518-520.
王雪玭,梁绵杰,沈云博,等.246例肺结节患者中医体质调查及多因素Logistic回归分析[J].中国急救复苏与灾害医学杂志,2021,16(11):1295-1299.
YM LI, X LI, HM CHEN, et al. Single-cell RNA sequencing reveals the multi-cellular ecosystem in different radiological components of pulmonary part-solid nodules[J/OL]. Clin Transl Med, 2022,12(2):e723 [2023-03-08]. https://onlinelibrary.wiley.com/doi/10.1002/ctm2.723.
XD XING, F YANG, Q HUANG, et al. Decoding the multicellular ecosystem of lung adenocarcinoma manifested as pulmonary subsolid nodules by single-cell RNA sequencing[J/OL]. Sci Adv, 2021,7(5):eabd9738 [2023-03-08]. https://www.science.org/doi/10.1126/sciadv.abd9738.
周仲瑛,程海波,周学平,等.中医药辨治肿瘤若干理念问题的探讨[J].南京中医药大学学报,2014,30(2):101-104.
程海波.癌毒病机理论探讨[J].中医杂志,2014,55(20):1711-1715.
FR HIRSCH, GV SCAGLIOTTI, JL MULSHINE, et al. Lung cancer: current therapies and new targeted treatments[J]. Lancet, 2017,389(10066):299-311.
NK ALTORKI, GJ MARKOWITZ, DC GAO, et al. The lung microenvironment: an important regulator of tumour growth and metastasis[J]. Nat Rev Cancer, 2019,19(1):9-31.
S SAAB, H ZALZALE, Z RAHAL, et al. Insights Into Lung Cancer Immune-Based Biology, Prevention, and Treatment[J/OL]. Front Immunol, 2020,11:159 [2023-03-08].https://www.frontiersin.org/articles/10.3389/fimmu.2020.00159/full.
郑舞,杨金坤.肿瘤微环境及其中医病机[J].中医杂志,2015,56(20):1720-1724.
程海波,沈卫星,吴勉华,等.基于肿瘤微环境的癌毒病机理论研究[J].南京中医药大学学报,2014,30(2):105-107.
H MACMAHON, DP NAIDICH, JM GOO, et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017[J]. Radiology, 2017,284(1):228-243.
FM KONG, TQ CHEN, XJ LI, et al. The Current Application and Future Prospects of Astragalus Polysaccharide Combined With Cancer Immunotherapy: A Review[J/OL]. Front Pharmacol, 2021,12:737674 [2023-02-20].https://www.frontiersin.org/articles/10.3389/fphar.2021.737674/full.
刘美红,邹峥嵘.女贞子化学成分、药理作用及药动学研究进展[J].热带亚热带植物学报,2022,30(3):446-460.
顾思浩,孔维崧,张彤,等.白术的化学成分与药理作用及复方临床应用进展[J].中华中医药学刊,2020,38(1):69-73.
崔鹤蓉,王睿林,郭文博,等.茯苓的化学成分、药理作用及临床应用研究进展[J].西北药学杂志,2019,34(5):694-700.
刘美霞,戚进,余伯阳.党参药理作用研究进展[J].海峡药学,2018,30(11):36-39.
李要远,花宝金,郑红刚.中医药参与肺结节临床管理的探讨[J].中国医药导报,2022,19(3):111-114.
刘玉莹,万少芬.化痰类中药在肺癌防治中的药理机制进展[J].四川中医,2020,38(5):218-220.
林洋,于大海,鹿红,等.活血化瘀中药改善肿瘤缺氧微环境研究进展[J].山西中医,2022,38(7):67-70.
徐洋洋,孙成新,丁侃.活血化瘀中药多糖的抗癌活性及其机制研究[J].上海中医药大学学报,2022,36(4):1-11.
李梦乾,张晓梅,李宝重,等. 从状态论治中危肺实性结节的随机对照临床研究[J]. 北京中医药大学学报,2023,46(4):551-556.
李峻,孟广松,陈明.补中益气汤合小柴胡汤对肺小结节患者肺功能及免疫炎症指标的影响[J].湖南中医药大学学报,2022,42(12):2083-2087.
于得海,毛真真,燕玉敏,等.调肺汤合解郁攻坚汤治疗肺小结节合并抑郁障碍临床研究[J].陕西中医,2021,42(11):1568-1571.
满君,张晓梅,闫宏.四逆散合升降散治疗三焦郁滞肺结节45例临床观察[J].中华中医药杂志,2020,35(8):4275-4277.
0
浏览量
12
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构